Quarterly report · Q3

Period2022-06-01 → 2023-02-28
Filed2023-04-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥3.1bn2022-06-01 → 2023-02-28Cons.Net sales
Revenue¥3.7bn2021-06-01 → 2022-05-31Cons.Net sales (5-year summary)
Revenue¥2.6bn2021-06-01 → 2022-02-28Cons.Net sales
Operating income¥260m2022-06-01 → 2023-02-28Cons.Operating income
Operating income¥375m2021-06-01 → 2022-02-28Cons.Operating income
Ordinary income¥286m2022-06-01 → 2023-02-28Cons.Ordinary income
Ordinary income¥450m2021-06-01 → 2022-05-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥375m2021-06-01 → 2022-02-28Cons.Ordinary income
Profit before tax¥248m2022-06-01 → 2023-02-28Cons.Income before income taxes
Profit before tax¥457m2021-06-01 → 2022-02-28Cons.Income before income taxes
Net income (owners)¥139m2022-06-01 → 2023-02-28Cons.Profit loss attributable to owners of parent
Net income (owners)¥380m2021-06-01 → 2022-05-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥332m2021-06-01 → 2022-02-28Cons.Profit loss attributable to owners of parent
Net income¥153m2022-06-01 → 2023-02-28Cons.Profit loss
Net income¥337m2021-06-01 → 2022-02-28Cons.Profit loss
Total assets¥3.3bnat 2023-02-28Cons.Assets
Total assets¥3.1bnat 2022-05-31Cons.Assets
Total assets¥2.7bnat 2022-02-28Cons.Total assets (5-year summary)
Total liabilities¥1.3bnat 2023-02-28Cons.Liabilities
Total liabilities¥1.4bnat 2022-05-31Cons.Liabilities
Net assets / equity¥2.0bnat 2023-02-28Cons.Net assets
Net assets / equity¥1.7bnat 2022-05-31Cons.Net assets
Net assets / equity¥1.7bnat 2022-02-28Cons.Net assets (5-year summary)
Cash and deposits¥1.2bnat 2023-02-28Cons.Cash and deposits
Cash and deposits¥1.1bnat 2022-05-31Cons.Cash and deposits
EPS (basic)¥15.612022-06-01 → 2023-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥0.952022-12-01 → 2023-02-28dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥43.442021-06-01 → 2022-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥38.062021-06-01 → 2022-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥9.692021-12-01 → 2022-02-28dCons.Basic earnings loss per share (5-year summary)
Equity ratio58.4%at 2023-02-28Cons.Equity to asset ratio (5-year summary)
Equity ratio54.1%at 2022-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio62.1%at 2022-02-28Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 45
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-06-01 → 2023-02-28¥3m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-06-01 → 2023-02-28¥3m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-06-01 → 2023-02-28¥3m
jpcrp040300-q3r_E24982-000Mediaplatformreportable segmentrevenue2022-06-01 → 2023-02-28¥769m
jpcrp040300-q3r_E24982-000Mediaplatformreportable segmentrevenue external2022-06-01 → 2023-02-28¥769m
jpcrp040300-q3r_E24982-000Mediaplatformreportable segmentrevenue intersegment2022-06-01 → 2023-02-28¥2,000
jpcrp040300-q3r_E24982-000Mediaplatformreportable segmentsegment profit2022-06-01 → 2023-02-28¥461m
jpcrp040300-q3r_E24982-000Medical B To Breportable segmentrevenue2022-06-01 → 2023-02-28¥117m
jpcrp040300-q3r_E24982-000Medical B To Breportable segmentrevenue external2022-06-01 → 2023-02-28¥117m
jpcrp040300-q3r_E24982-000Medical B To Breportable segmentrevenue intersegment2022-06-01 → 2023-02-28¥17,000
jpcrp040300-q3r_E24982-000Medical B To Breportable segmentsegment profit2022-06-01 → 2023-02-28¥29m
jpcrp040300-q3r_E24982-000Medical Institution Management Supportreportable segmentrevenue2022-06-01 → 2023-02-28¥2.2bn
jpcrp040300-q3r_E24982-000Medical Institution Management Supportreportable segmentrevenue external2022-06-01 → 2023-02-28¥2.2bn
jpcrp040300-q3r_E24982-000Medical Institution Management Supportreportable segmentrevenue intersegment2022-06-01 → 2023-02-28¥213,000
jpcrp040300-q3r_E24982-000Medical Institution Management Supportreportable segmentsegment profit2022-06-01 → 2023-02-28¥64m
—segment totalrevenue2022-06-01 → 2023-02-28¥3.1bn
—segment totalrevenue external2022-06-01 → 2023-02-28¥3.1bn
—segment totalrevenue intersegment2022-06-01 → 2023-02-28¥233,000
—segment totalsegment profit2022-06-01 → 2023-02-28¥554m
Total Of Reportable Segments And Otherssegment totalrevenue2022-06-01 → 2023-02-28¥3.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-06-01 → 2023-02-28¥3.1bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-06-01 → 2023-02-28¥233,000
Total Of Reportable Segments And Otherssegment totalsegment profit2022-06-01 → 2023-02-28¥556m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-06-01 → 2022-02-28¥3m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-06-01 → 2022-02-28¥3m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-06-01 → 2022-02-28¥3m
jpcrp040300-q3r_E24982-000Mediaplatformreportable segmentrevenue2021-06-01 → 2022-02-28¥733m
jpcrp040300-q3r_E24982-000Mediaplatformreportable segmentrevenue external2021-06-01 → 2022-02-28¥733m
jpcrp040300-q3r_E24982-000Mediaplatformreportable segmentsegment profit2021-06-01 → 2022-02-28¥480m
jpcrp040300-q3r_E24982-000Medical B To Breportable segmentrevenue2021-06-01 → 2022-02-28¥115m
jpcrp040300-q3r_E24982-000Medical B To Breportable segmentrevenue external2021-06-01 → 2022-02-28¥115m
jpcrp040300-q3r_E24982-000Medical B To Breportable segmentrevenue intersegment2021-06-01 → 2022-02-28¥10,000
jpcrp040300-q3r_E24982-000Medical B To Breportable segmentsegment profit2021-06-01 → 2022-02-28¥47m
jpcrp040300-q3r_E24982-000Medical Institution Management Supportreportable segmentrevenue2021-06-01 → 2022-02-28¥1.7bn
jpcrp040300-q3r_E24982-000Medical Institution Management Supportreportable segmentrevenue external2021-06-01 → 2022-02-28¥1.7bn
jpcrp040300-q3r_E24982-000Medical Institution Management Supportreportable segmentrevenue intersegment2021-06-01 → 2022-02-28¥699,000
jpcrp040300-q3r_E24982-000Medical Institution Management Supportreportable segmentsegment profit2021-06-01 → 2022-02-28¥123m
—segment totalrevenue2021-06-01 → 2022-02-28¥2.6bn
—segment totalrevenue external2021-06-01 → 2022-02-28¥2.6bn
—segment totalrevenue intersegment2021-06-01 → 2022-02-28¥710,000
—segment totalsegment profit2021-06-01 → 2022-02-28¥651m
Total Of Reportable Segments And Otherssegment totalrevenue2021-06-01 → 2022-02-28¥2.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-06-01 → 2022-02-28¥2.6bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-06-01 → 2022-02-28¥710,000
Total Of Reportable Segments And Otherssegment totalsegment profit2021-06-01 → 2022-02-28¥654m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 364
ItemContextValueUnit
Notes regarding dividend (text)CurrentYTDDurationText · Plus
Notes when there is significant changes in amounts of equity (text)CurrentYTDDurationText · Plus
Notes segment information etc quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Footnotes regarding segment information table (text)Prior1YTDDurationText · Plus
Description of nature of differences between profit loss of reportable segments total and quarterly financial statements (text)Prior1YTDDurationText · Plus
Information about impairment loss of non current assets or goodwill etc for each reportable segment (text)Prior1YTDDurationText · Plus
Footnotes regarding segment information table (text)CurrentYTDDurationText · Plus
Description of nature of differences between profit loss of reportable segments total and quarterly financial statements (text)CurrentYTDDurationText · Plus
Notes revenue recognition quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Notes business combinations quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Notes per share information quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Notes significant events after reporting period quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Other information consolidated financial statements etc (text)CurrentYTDDurationText · Plus
Information about company which provides guarantee to reporting company (text)FilingDateInstantText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-05-31pass rounding
balance sheet identityconsolidated 2023-02-28pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-05-31pass
statement vs summary · net assetsconsolidated 2023-02-28pass
statement vs summary · net income attributable to parentconsolidated 2021-06-01/2022-02-28pass
statement vs summary · net income attributable to parentconsolidated 2022-06-01/2023-02-28pass
statement vs summary · revenueconsolidated 2021-06-01/2022-02-28pass
statement vs summary · revenueconsolidated 2022-06-01/2023-02-28pass
statement vs summary · total assetsconsolidated 2022-05-31pass
statement vs summary · total assetsconsolidated 2023-02-28pass